Form 4 for TSHA Taysha Gene Therapies, Inc.
Accepted 2022-02-04 00:00:00 ET · period of report 2022-02-02 · accession 0001209191-22-007126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-02-04 | 2022-02-02+ | TSHA | Manning Paul B | Dir, 10% | P - Purchase | $7.79 | +93.6K | 2.07M | +5% | +$729.1K |
| M | 2022-02-04 | 2022-02-02+ | TSHA | Manning Paul B | Dir, 10% | P - Purchase | $7.80 | +108.0K | 92.2K | New | +$842.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-03 | P | A | 26,602 | $7.84 | 2,091,704 | I | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.725 to $8.00 inclusive. |
| 2 | Common | Common Stock | 2022-02-03 | P | A | 50,000 | $7.84 | 142,202 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.725 to $8.00 inclusive. (F2) Shares held by Mr. Manning jointly with his spouse. |
| 3 | Common | Common Stock | 2022-02-02 | P | A | 22,000 | $7.77 | 22,000 | I See footnote | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.63 to $7.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (5). (F3) The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. |
| 4 | Common | Common Stock | 2022-02-02 | P | A | 58,000 | $7.77 | 92,202 | D See footnote | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.63 to $7.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (5). (F2) Shares held by Mr. Manning jointly with his spouse. (F3) The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. |
| 5 | Common | Common Stock | 2022-02-02 | P | A | 45,000 | $7.77 | 2,065,102 | I See footnote | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.63 to $7.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (5). (F4) The shares are held directly by BKB G2 Investments LLC ("BKB G2"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB G2, and has shared voting and investment power with respect to the shares held by BKB G2. |